Ophthalmic Drugs Market Latest Innovations, Research, Segment, Growth Rate and Global Forecast 2027
The rise in the number of visually impaired population is increasing in tandem with the rise in geriatric population. Eye diseases such as Retinal Vein Occlusion (RVO), Wet AMD, Myopic Choroidal Neovascularization (mCNV), diabetic retinopathy, and others are on the rise which generates high demand for ophthalmic drugs. Moreover, a rise in the volume of cataract surgeries followed by a high incidence rate of glaucoma and dry eye are among major growth factors for the global ophthalmic drugs market . The global ophthalmic drugs market is estimated to expand at a CAGR of 6% over the forecast period of 2017-2023, predicts Market Research Future (MRFR) in a detailed study. Cutting edge research and development activities by pharmaceutical companies to develop drugs which can cater to the huge unmet needs of the population have resulted in innovation in the ophthalmic drugs industry . In recent years, the market has witnessed a substantial rise in the number of US FDA approvals for no